drugset / Trial / NCT01207089

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329

NCT01207089 ↗

Phase 1 Completed 45 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindBasic science

Summary

The purpose of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8329 following multiple ascending dose administrations in in overweight to obese but otherwise healthy male subjects.

Timeline

Start
2010-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8329 Unknown — Oral

Indications